One person dies every 50 seconds in the U.S. from cancer, and an estimated 39% of people in the country will develop cancer during their lifetime. Survival rates have improved in recent decades from innovations and combinations of treatments, including surgery, chemotherapy, radiation, immunotherapy and biotechnology. Still, some cancers resist treatment or recur.
State health authorities ask patients to stop using flagged batches as 70 drug samples produced in the state fail critical ingredient tests while 22 show minor defects.
